A further up-regulation of TLR5 was observed in normal B lymphocytes and, to a lesser extent, in MCL cells activated with CD40L and IL-4 and treated with a TLR5 ligand (Fig 1B). Here, CD40LG is linked to mantle cell lymphoma.